{'fraction_non_alphanumeric': 0.024600246002460024, 'fraction_numerical': 0.004920049200492005, 'mean_word_length': 5.898305084745763, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Melbourne Convention Centre Floor Plan

Welcome to the 2013 Annual Scientific Meeting (ASM) of the Medical Oncology Group of Australia Incorporated (MOGA), Blood, Biomarkers and Beyond. Our aim in developing a scientific program for this year’s ASM was to focus on important, current research, clinical and professional oncology issues around biomarkers. Biomarkers are likely to play a pivotal role in the routine management of patients with cancer and guide drug development in this era of targeted therapy. This year’s meeting provides practical information about biomarkers as tools for screening, diagnosis and treatment; translational biomarker issues; and practical aspects of biomarker development, including future applications in translational research, drug development, research and clinical practice.